Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort.

D Doppenberg,F J Lagerwaard,S van Dieren,M R Meijerink,J J van der Vliet,M G Besselink,G van Tienhoven, E Versteijne,B J Slotman,J W Wilmink,G Kazemier,A M E Bruynzeel

Frontiers in oncology（2023）

引用 0|浏览17

暂无评分

摘要

SABR is a well-tolerated treatment in patients with unresectable LAPC following chemotherapy, with better outcomes when applied in patients with higher performance score, age <70 years and absence of pain. Future randomized trials will have to confirm these findings.

查看译文

关键词

advanced pancreatic cancer,stereotactic ablative radiotherapy,initial chemotherapy,patient selection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要